🏛️ EPO Munich
EPO T 0250/25
Court
EPO Board of Appeal 3.3.05 (Munich)
Type of action
opposition appeal
Language
en
Claimant / applicant
- Novo Nordisk A/S
Defendant / respondent
- GlaxoSmithKline Intellectual Property Development Limited
- European Oppositions Limited
Track this case
Get an email when a new order or decision is published in EPO T 0250/25.
Decisions and documents (1)
- 2026-10-05appeal decision
Amendments - allowable (yes); Priority - same invention (yes); Novelty - (yes); Inventive step - (yes)
Weekly digest
A weekly email summarising new published decisions across European patent courts.